admera_health_final_logo_transparent_final.jpg
Associates in Cardiovascular Disease and Admera Health Unveiled a Health Economics Model at the 2017 National Lipid Association Conference Detailing the Cost Benefits of Genetic Testing for Familial Hypercholesterolemia
May 23, 2017 09:25 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., May 23, 2017 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company developing comprehensive genetic tests for risk assessment and early diagnosis of...
NLA LOGO - USE.png
PCSK9 Barriers Survey Results Revealed at National Lipid Association Conference
February 07, 2017 09:30 ET | National Lipid Association
PHOENIX, AZ--(Marketwired - February 07, 2017) - As part of its Spring Clinical Lipid Update (CLU) in Phoenix, the National Lipid Association (NLA) will reveal the results of its "Challenges in...
NLA LOGO - USE.png
Leading Cardiologist Dr. Neil Stone Secured as Speaker for the National Lipid Association Conference
July 18, 2016 12:47 ET | National Lipid Association
JACKSONVILLE, FL--(Marketwired - July 18, 2016) - Award-winning cardiologist, Neil J. Stone, MD, FACC, FNLA, will be the keynote speaker at the National Lipid Association (NLA) Clinical Lipid Update...
admera_health_final_logo_transparent_final.jpg
Admera Health Launches Molecular Test for Inherited Early Atherosclerosis Diagnosis and Risk
March 17, 2016 07:00 ET | Admera Health, LLC
SOUTH PLAINFIELD, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Admera Health (www.admerahealth.com), a commercial stage New Jersey based Precision Medicine and Digital Health company announced today the...
NLA LOGO - USE.png
National Lipid Association Releases Its Annual Summary of Clinical Lipidology 2016
February 22, 2016 11:37 ET | National Lipid Association
JACKSONVILLE, FL--(Marketwired - February 22, 2016) - The National Lipid Association's (NLA) Annual Summary of Clinical Lipidology 2016 was just published the Journal of Clinical Lipidology....
Amaranth Medical
Amaranth Medical Completes MEND-II and RENASCENT Studies and Initiates Study of 120-Micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
October 15, 2015 08:00 ET | Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that enrollment has successfully concluded in its multi-center, international...
SHAPE Logo
Six Additional East Texas Medical Center Hospitals Certified as SHAPE Centers of Excellence
August 06, 2015 06:00 ET | SHAPE
HOUSTON, Aug. 6, 2015 (GLOBE NEWSWIRE) -- SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit grassroots organization dedicated to the mission of...
Amaranth Medical
Amaranth Medical Reports Findings from Two FORTITUDE Bioresorbable Scaffold Studies at EuroPCR 2015
May 18, 2015 15:12 ET | Amaranth Medical, Inc.
Mountain View, CA, May 18, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced plans to report clinical results from the Company's ongoing trial of...
North Shore Long Island Jewish Health System logo
Feinstein Institute Presents Cerami Award to Karolinska Institutet Researcher
September 05, 2014 09:10 ET | North Shore Long Island Jewish Health System
MANHASSET, N.Y., Sept. 5, 2014 (GLOBE NEWSWIRE) -- The Feinstein Institute for Medical Research and Molecular Medicine announced today that it will confer the second Anthony Cerami Award in...
Amaranth Medical
Amaranth Medical Announces Investment from Boston Scientific
January 14, 2014 09:14 ET | Amaranth Medical, Inc.
Mountain View, CA, Jan. 14, 2014 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, today announced the closing of an equity investment by Boston Scientific Corporation...